Mealtime Glycemic Excursions in Pediatric Subjects with Type 1 Diabetes: Results of the Diabetes Research in Children (DirecNet) Accuracy Study Study Group.

Slides:



Advertisements
Similar presentations
Role of Amylin and Glucagon in Postprandial Glycemic Excursions in Pediatric Type 1 Diabetes. Rubina Heptulla MD, Luisa M. Rodriguez MD and Morey W. Haymond.
Advertisements

Oxford University Hospitals NHS Trust Injectable medicines study day:
Advanced Pumping. Objectives: Identify situations to utilize temporary basal rate in pump therapy patients. Identify examples of when to use combination.
Down Alert Function of the GlucoWatch® G2 TM Biographer (GW2B) During Insulin- induced Hypoglycemia in Children Eva Tsalikian 1, Craig Kollman 2, Rosanna.
INTRODUCTION TO CONTINUOUS GLUCOSE MONITORS
Diabetes Self-Management Profile- Revised for Conventional and Flexible Insulin Regimens Wysocki, T. 1, Xing, D. 2, Fiallo-Scharer, R. 3, Doyle, E. 4,
Continuous Glucose Monitoring. Diabetes Management Evolution Insulin Delivery Glucose Monitoring 2000 First CGM system 2006 Paradigm REAL- Time, combining.
1 GLUCOWATCH ® G2™ BIOGRAPHER H. PETER CHASE, MD I)INTRODUCTION II)ACCURACY DATA III) HOME PILOT TRIAL IV) DIRECNET STUDY GROUP V) SUMMARY.
Diabetes Control in Youth: The American Experience Georgeanna J. Klingensmith, MD Keystone Colorado July 2008.
DAVID C KLONOFF, MD Medical Director Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Health Services Clinical Professor of.
INPATIENT DIABETES GUIDE Ananda Nimalasuriya M.D..
Diabetes Update: Living Life after Lente
1 INTRODUCTION TO CONTINUOUS GLUCOSE MONITORS H. Peter Chase, MD Vicky Gage, RN, CDE Laurel Messer, RN, CDE Susie Owen, RN, CDE Sally Sullivan, RN, CDE.
Insulin therapy.
1 Progress Towards an Artificial Pancreas for T1D WILLIAM TAMBORLANE, MD Chief of Pediatric Endocrinology, Yale University, Deputy Director, Yale Center.
Suhyla Alam (Eastern Virginia Medical School), Amy West, Maura Downey, Jane EB Reusch, Kristen Nadeau University of Colorado Denver and Children’s Hospital.
Accuracy of the FreeStyle Navigator ™ Continuous Glucose Monitor Diabetes Research in Children Network Larry Fox, 1 Roy Beck, 2 Stuart Weinzimer, 3 Katrina.
Management Tools and CGM Kathryn Moe, RN CDE Medtronic Diabetes.
Diabetes Research in Children Network (DirecNet) Outpatient Pilot Study to Evaluate the GlucoWatch® G2 TM Biographer in the Management of Type 1 Diabetes.
Accuracy of the A1cNow ® in Children with T1D. Diabetes Research in Children Network Larry Fox, 1 Dongyuan Xing, 2 Katrina Ruedy, 2 Roy Beck, 2 Craig Kollman,
Limitations of Statistical Measures of Error in Assessing the Accuracy of Glucose Sensors Craig Kollman1, Darrell Wilson2, Tim Wysocki3, Rosanna Fiallo-Scharer4,
INSULIN THERAPY IN TYPE 1 DIABETES
Practical Aspects of Continuous Glucose Monitoring 2008 Rosanna Fiallo-Scharer, MD Laurel Messer, RN, BSN, CDE Barbara Davis Center for Childhood Diabetes.
Diabetes Research in Children Network (DirecNet) Outpatient Pilot Study to Evaluate the Feasibility of Computer-Based Data Acquisition and Transmission.
A 5-center CRC-based Study of the Accuracy of the GlucoWatch® G2 TM Biographer in Children and Adolescents with Type 1 Diabetes Darrell Wilson 1, Bruce.
Inhaled Human Insulin Treatment in Patients with Type 2 Diabetes Mellitus Matthew Faiman.
Diabetes Technology Update
Module 3 Initial Recognition, Triaging, and Management of Hyperglycemia Diabetes Special Interest Group Georgia Hospital Association.
Presented by Dr. Soe Sandi Tint
L.M. Fisk, A.J. Le Compte, G.M. Shaw, S. Penning, T. Desaive, J.G. Chase Pilot Trial of STAR in Medical ICU INTRODUCTION Background: Accurate glycemic.
An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia.
Abstract Background: As part of a study to evaluate the accuracy of the GlucoWatch ® G2 TM Biographer and the Continuous Glucose Monitoring System (CGMS.
Diabetes Control and Complications Trial (DCCT) Results indicate that most youth with T1DM should be treated intensively in order to reduce the risk of.
Background: DirecNet Diabetes Research in Children Network NIH funded collaborative study group 5 clinical centers, central laboratory, coordinating center,
Diabetes Research in Children Network Pilot Study of the Navigator TM Continuous Glucose Monitoring System in Children with Type 1 Diabetes: Safety, Tolerability,
Journal Club 埼玉医科大学 総合医療センター 内分泌・糖尿病内科 Department of Endocrinology and Diabetes, Saitama Medical Center, Saitama Medical University 松田 昌文 Matsuda, Masafumi.
Event-Based Assessments of Sensor Accuracy during Exercise-Induced Reductions in Glucose in Children with Type 1 Diabetes Craig Kollman, 1 Darrell Wilson,
Impact of Exercise on Overnight Glycemic Control in Children with Type 1 Diabetes (T1DM) Eva Tsalikian 1 ; Roy Beck 2 ; Peter Chase 3 ; Tim Wysocki 4 ;
Internet-based pilot study comparing low fat with high fat evening snacks in children and adolescents with Type 1 Diabetes using continuous glucose monitoring.
Use of The FreeStyle Navigator TM Continuous Glucose Monitoring System in Children on Glargine- based Multiple Daily Injection Therapy Stuart Weinzimer.
Use of the FreeStyle Navigator ™ Continuous Glucose Monitoring System in Children with Type 1 Diabetes Diabetes Research in Children Network L. A. Fox,
Lack of Effectiveness of the GlucoWatch Biographer (GW2B) in Altering Glycemic Control in Children with Type 1 Diabetes H. Peter Chase 1, Roy Beck 2, William.
A Comparison of the Original vs. Modified Continuous Glucose Monitoring System (CGMS™) Sensor During Hypoglycemia in the Diabetes Research in Children.
Utility of CGMS as a Measure of Glycemic Control in Children with Type 1 Diabetes (T1DM) Rosanna Fiallo-Scharer, MD for.
Reliability of two indices of the biologic variability in glycosylation among children and adolescents with T1DM Darrell M Wilson 1, Rosanna Fiallo-Scharer.
Effectiveness of Early Intensive Therapy On β-Cell Preservation in Type 1 Diabetes Featured Article: Bruce Buckingham, M.D., Roy W. Beck, M.D., P.H.D.,
1 Part 2 Routinely Identifying Postprandial Hyperglycemia - Challenges & Tools An Educational Service from G LYCO M ARK G LYCO M ARK is a registered trademark.
OLSON, M.L., ET AL Vitamin D Deficiency in Obese Children an Its Relationship to Glucose Homeostasis J Clin Endocrinol Metab, 97, , 2012.
Evaluation of Factors Affecting CGMS Calibration Bruce Buckingham, 1 Craig Kollman, 2 Roy W Beck, 2 Andrea Kalajian, 2 Rosanna Fiallo-Scharer, 3 Michael.
Accuracy Study of the Medtronic Minimed Continuous Glucose Monitoring System (CGMS) and GlucoWatch® G2TM Biographer (GW2B) in Children with Type 1 Diabetes.
Alterations in White Matter Structure in Young Children With Type 1 Diabetes Featured Article: Naama Barnea-Goraly, Mira Raman, Paul Mazaika, Matthew Marzelli,
Performance of the DCA 2000 ® + Analyzer for Measurement of Hemoglobin A1 c Levels in Children with T1DM in a DirecNet Outpatient Clinical Trial.
INSULIN PUMPS Shelby Polk DNP, FNP-BC, CDE. 2 MANAGEMENT OF DIABETES IN SCHOOLS Exercise Legal Rights Health & Learning Nutrition Insulin Administration.
DirecNet Study of the Accuracy of the Navigator Continuous Glucose Monitoring System in Children and Adolescents with Type 1 Diabetes Darrell Wilson 1,
Introduction (Background) Obesity epidemic in childhood has led to increased emphasis on hypertension and early cardiovascular disease. Ambulatory blood.
The Physiological Variations of Plasma Glucose Concentrations in Healthy, Non-Diabetic Children: Use of Continuous Glucose Sensors Nelly Mauras, Roy Beck,
ADDITIONAL SLIDES FOR ASSIST WITH COMPREHENSION OF LAB CONTENT-MODULE FIVE-DM DENISE TURNER, MS-N.ED, RN, CCRN.
TEMPLATE DESIGN © CONTINUOUS GLUCOSE MONITORING, ORAL GLUCOSE TOLERANCE, AND INSULIN – GLUCOSE PARAMETERS IN ADOLESCENTS.
Date of download: 6/24/2016 From: Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus: A Systematic.
Dr Zaranyika MBChB(Hons) UZ, MPH, FCP SA Department of Medicine UZ-CHS
Date of download: 6/26/2016 From: Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus: A Systematic.
Changes in the concentration of serum C-peptide in type 2 diabetes during long-term continuous subcutaneous insulin infusion therapy Department of Internal.
Key publication slides
Key publication slides
Copyright © 2004 American Medical Association. All rights reserved.
New Patient-Friendly Options for Managing Insulin Dosing
Faster-Acting Insulins
INSULINS Dr.R.Sajjad december INSULINS Dr.R.Sajjad december 2018.
Insulin Delivery Systems Atlanta Diabetes Associates
Twice daily regimen N=45 MDI regimen N=28 P Value
Presentation transcript:

Mealtime Glycemic Excursions in Pediatric Subjects with Type 1 Diabetes: Results of the Diabetes Research in Children (DirecNet) Accuracy Study Study Group

Background The Diabetes Research in Children Network (DirecNet) is a multi-center group whose aim is to study the accuracy and practicability of glucose sensor systems in children with type 1 diabetes (T1DM) Meal-related hyperglycemic excursions contribute greatly to difficulty in optimal diabetes control Continuous glucose monitoring systems provide the opportunity to study meal-related glucose excursions

Objectives To describe meal-related glycemic excursions in children and adolescents with T1DM To determine the accuracy of the Continuous Glucose Monitoring System (CGMS, Medtronic MiniMed, Inc.) and the GlucoWatch ® G2™ Biographer (GW2B, Cygnus, Inc.) under rapidly changing glucose levels

Methods 82 children with T1DM admitted to 5 CRCs CGMS, GW2B, blood-drawing IV inserted Short-acting or meal-related bolus insulin omitted Standard liquid carbohydrate meal administered, 1.75 gm/kg (max 75 gm) Reference venous blood glucose (BG) measured at baseline and every 5 min for up to 60 min Sensor glucose (SG) levels compared to reference BG

Subject Demographics Gender F / M41 / 41 Age mean ± SD (y)10.4 ± 4.1 Race / Ethnicity N(%) White73 (89) Hispanic or Latino4 (5) African-American3 (4) Other2 (2) BMI percentile mean ± SD (%)67 ± 23

Clinical Characteristics Duration of T1DM mean ± SD (y) All ages4.9 ± < 7 (n = 23)3.2 ± < 12 (n = 27)3.8 ± < 18 (n = 32)7.0 ± 3.9 Insulin Route N (%) Pump38 (46) Multiple daily injection44 (54) HbA1c mean ± SD (%)7.7 ± 1.1

BG Distribution at each 5-minute interval during meal-induced Hyperglycemia test Time since start of test (min) Glucose (mg/dL)

Baseline and Peak Glucose Levels by Age and Treatment Modality* Overall1 - < 77 - < < 18CSIIMDI Blood Glucose (mg/dL) BaselinePeak *Height of bar = mean Whisker = mean + 1 SD

Time to peak BG (min) Overall1 - < 77 - < < 18CSIIMDI Rate of Change (mg/dL-min) Time Course of Glucose Excursion by Age and Treatment Modality* Restricted to n=62 subjects in whom hyperglycemia was successfully induced (increase of 100 mg/dL or doubling from baseline) *Height of bar = mean Whisker = mean + 1 SD

Sensor Accuracy According to Rate of Glucose Change During Test Median Relative Absolute Deviation Rate of Change* (mg/dL per min) Accuracy did not vary by rate of change. *Calculated from the previous reference glucose value (drop in BG divided by minutes between values)

Fulfillment of ISO Criteria* According to Rate of Glucose Change During Test Accuracy did not vary by rate of change *ISO criteria: for reference BG ≤75 mg/dL, SG within ±15 mg/dL for reference BG >75 mg/dL, SG value within ±20% % Meeting ISO Criteria Rate of Change (mg/dL per min)

Conclusions Magnitude, timing, and rate of meal-related hyperglycemic excursions were consistent across all age groups Sensor accuracy was not affected by rapid increases in BG levels Sensor performance during rapid glucose changes met ISO criteria for 51-72% of SG readings

Barbara Davis Center –H. Peter Chase –Rosanna Fiallo-Scharer –Jennifer Fisher University of Iowa –Eva Tsalikian –Michael Tansey –Linda Larson Nemours Children’s Clinic –Tim Wysocki –Nelly Mauras –Kristen Gagnon Stanford University –Bruce Buckingham –Darrell Wilson –Jennifer Block Yale University –William Tamborlane –Stuart Weinzimer –Elizabeth Boland Jaeb Center for Health Research –Roy Beck –Katrina Ruedy –Craig Kollman –Andrea Booth –Gladys Bernett

Abstract Mealtime Glycemic Excursions in Pediatric Subjects with Type 1 Diabetes Mellitus (T1DM): the DirecNet Experience Stuart Weinzimer 1, Roy Beck 2, Katrina Ruedy 2, Andrea Booth 2, Elizabeth Boland 1, and the Diabetes Research in Children Network (DirecNet) Study Group. 1 Department of Pediatrics, Yale University School of Medicine, New Haven, CT and 2 Jaeb Center for Health Research, Tampa, FL. Background: DirecNet is a multi-center network whose aim is to study glucose sensing systems in children with T1DM. A meal protocol, in which a standard carbohydrate load was administered to test the accuracy of these sensors during changing blood glucose (BG) conditions, provided the opportunity to study the magnitude and timing of hyperglycemic excursions in children with T1DM. Objective: To describe the BG excursions in children with T1DM after a standard meal challenge and determine their relationship to patient factors. Design/Methods: 82 subjects with T1DM (41F, 41M, mean age 10  4 y [range 3-17 y]) were admitted to the CRC for metabolic monitoring. After oral ingestion of a standard liquid simple carbohydrate meal (1.75 gm/kg, maximum 75 gm), venous BG measurements were obtained at baseline and every 5 minutes for up to 60 minutes. Subjects using multiple daily injections (MDI) delayed their insulin injection, and pump subjects continued basal insulin delivery but delayed bolus insulin, until meal test completion. Results: BG increased from a mean baseline of 148  65 mg/dL to a peak of 283  78 mg/dL. Mean time to peak BG was 56  9 min. Among subjects who increased at least 100 mg/dL or 100% from baseline (N=62), mean rate of rise of BG was 3.4  1.1 mg/dL-min from start of increase to peak glucose. Magnitude of time to glucose peak, and rate of change of blood glucose were similar comparing the MDI and insulin pump-treated subjects. Conclusions: This standardized carbohydrate load induced a large hyperglycemic excursion, which was relatively consistent across all age groups and treatment modalities. Notably, the timing of BG rise was slower than anticipated, particularly in the first 15 minutes, which has important therapeutic implications regarding conventional treatment of hypoglycemia in T1DM with oral carbohydrates.